BiotechTube
Saronic Biotechnology

Saronic Biotechnology

Cambridge, United States· Est.
saronicbiotechnology.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $60M

Overview

Saronic Biotechnology is a private, preclinical-stage biotech company targeting hepatocellular carcinoma (HCC) with novel immunotherapies. Its lead candidate, SBI1997, is a cellular immunotherapy designed to prime the immune system to prevent cancer recurrence. Founded in 2021, the company is led by a team with deep expertise in liver disease and oncology, operating in the high-need but competitive cell and gene therapy sector for solid tumors.

OncologyHepatology

Technology Platform

Novel cellular immunotherapy platform designed to prime the immune system to detect and destroy tumor-specific cells, focusing on preventing cancer recurrence.

Funding History

2
Total raised:$60M
Series A$55M
Seed$5M

Opportunities

The large and growing global market for HCC treatments, particularly for adjuvant therapies that prevent recurrence, represents a multi-billion dollar opportunity.
Advances in cell engineering and a deeper understanding of liver immunology provide a technological tailwind for novel immunotherapy approaches.

Risk Factors

High scientific risk associated with developing effective cellular therapies for solid tumors like HCC.
Significant financial risk as a pre-revenue, early-stage private company requiring continuous capital infusion.
Intense competition from large pharma and other biotechs in the oncology immunotherapy space.

Competitive Landscape

The HCC treatment landscape is competitive, dominated by tyrosine kinase inhibitors and immune checkpoint inhibitors from major pharmaceutical companies. The cellular therapy space for solid tumors is less crowded but includes several well-funded biotechs. Saronic will need to demonstrate clear differentiation in efficacy, safety, or manufacturing to succeed.

More companies in Immunotherapy / Immuno-Oncology →More companies in United States →